EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulation of Kv2.1 biogenesis and gating by candidate disease-linked Kv6.1 variants

Damayantee Das, Shawn M Lamothe, Nicholas C Duta, Chloe C Koens, Yubin Hao, P Y Billie Au, Harley T Kurata

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2025.110943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Damayantee Das und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Shab Potassium Channels, Ion Channel Gating, Mutation, Missense. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, Institute of Neurosciences Mental Health and Addiction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silent voltage-gated potassium channel subunits are enigmatic ion channels in the Kv5, Kv6, Kv8, and Kv9 families, which do not generate functional homomers, but instead assemble and modify the function of Kv2 family channels. While these biophysical consequences have been recognized, knowledge on physiological roles and pathologies associated with silent voltage-gated potassium channel subunits is not well developed. In this study, we investigated the functional effects of two Kv6.1 variants identified in either a pediatric patient (Kv6.1[L284P]), or a calf (Kv6.1[W416C]), which exhibited anatomical abnormalities. Kv2.1 current was reduced significantly when coexpressed with either Kv6.1 or Kv6.1[L284P], and even more dramatically with Kv6.1[W416C], which led to nearly complete suppression of Kv2.1 current. These mutants also attenuated Kv6.1-mediated effects on inactivation of Kv2.1. Interestingly, protein expression levels of Kv6.1 variants are not significantly affected when subunits are expressed alone. However, coexpression with Kv2.1 decreases expression of both Kv2.1 and Kv6.1 (and variants), and this effect is particularly powerful for Kv6.1[W416C]. Additionally, we report that Kv2.1 promotes phosphorylation of Kv6.1, but this is largely absent in the Kv6.1[W416C] mutant. Overall, effects of Kv6.1[W416C] are prominent, while Kv6.1[L284P]-mediated effects are much weaker and often difficult to distinguish from WT Kv6.1, and a direct causal link to anatomical abnormalities will require further investigation. Our findings highlight that Kv6.1 and variants influence expression and gating properties of Kv2.1, and also that coassembly with Kv2.1 leads to previously unrecognized posttranslational modifications of Kv6.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shab Potassium ChannelsIon Channel GatingMutation, MissenseHumansAnimalsCattleHEK293 CellsPhosphorylationAmino Acid Substitution

Stichwörter der Autor:innen

Kv2.1Kv6.1anatomical dysmorphismgenetic diseasephosphorylationposttranslational modification (PTM)potassium channel

Substanzen

Shab Potassium ChannelsKCNB1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
  • Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: kurata@ualberta.ca.

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Canadian Institutes of Health Research
  • Institute of Neurosciences Mental Health and Addiction

Zitieren

APA

Das, D., Lamothe, S. M., Duta, N. C., Koens, C. C., Hao, Y., Au, P. Y. B., & Kurata, H. T. (2026). Regulation of Kv2.1 biogenesis and gating by candidate disease-linked Kv6.1 variants. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110943

Vancouver

Das D, Lamothe SM, Duta NC, Koens CC, Hao Y, Au PYB, et al. Regulation of Kv2.1 biogenesis and gating by candidate disease-linked Kv6.1 variants. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.110943

BibTeX
@article{Das2026,
  author = {Das, Damayantee and Lamothe, Shawn M and Duta, Nicholas C and Koens, Chloe C and Hao, Yubin and Au, P Y Billie and Kurata, Harley T},
  title = {Regulation of Kv2.1 biogenesis and gating by candidate disease-linked Kv6.1 variants},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2025.110943}
}
Kostenlos starten →